Study ID: C37440/1108

Study Title

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Teva Identifier

C37440/1108

ClinicalTrials.gov Identifier

NCT01922752

Study Status

Completed

Trial Condition(s)

Solid Tumors

Interventions

Drug: CEP-37440

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
cancer icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

07/01/2013 - 12/01/2015

Phase

Phase 1

Study Type

Interventional